Skip to search formSkip to main contentSkip to account menu

CYP4F2 gene

Known as: CYTOCHROME P450, SUBFAMILY IVF, POLYPEPTIDE 2, CYP4F2, cytochrome P450 family 4 subfamily F member 2 
National Institutes of Health

Related topics

Related topics

1 relation
CYP4F2 protein, human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
In Vitro Inhibitory Effects of Sesamin on CYP4F2 Activity.
Sesamin is a major lignan in sesame seeds, and a recent meta-analysis of controlled trials indicated that sesamin intake… 
2018
2018
Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE).
Review
2018
Review
2018
Cytochrome P450 family 4 subfamily F member 2 (CYP4F2) rs1558139, rs2108622 polymorphisms and susceptibility to several cardiovascular and cerebrovascular diseases
BackgroundInconsistent conclusions have been reported for the genetic relationship between CYP4F2 (Cytochrome P450 Family 4… 
2017
2017
CYP4F2 repression and a modified alpha-tocopherol (vitamin E) metabolism are two independent consequences of ethanol toxicity in human hepatocytes.
2017
2017
20-Hydroxyeicosatetraenoic acid regulates the expression of Nedd4‑2 in kidney and liver through a neddylation modification pathway.
The present study aimed to test whether 20-hydroxyeicosatetraenoic acid (20‑HETE) affected neddylation modification of E3‑ligase… 
2014
2014
Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.
AIM Warfarin, a widely used anticoagulant, exhibits large interindividual variability in dose requirements. CYP2C9 and VKORC1… 
2014
2014
CYP4F2 1347 G>A & GGCX 12970 C>G polymorphisms: frequency in north Indians & their effect on dosing of acenocoumarol oral anticoagulant
Background & objectives: CYP4F2 and γ-glutamyl carboxylase (GGCX) have small but significant roles in the maintenance dose of… 
2013
2013
ω-Hydroxylation of phylloquinone by CYP4F2 is not increased by α-tocopherol.
SCOPE The objective of this study was to investigate the initial catabolic step of vitamin E and K metabolism, the… 
2012
2012
Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindione.
AIM Genetic variants of the enzyme that metabolizes warfarin, cytochrome P-450 2C9 (CYP2C9) and of a key pharmacologic target of… 
2012
2012
CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy
Warfarin is a commonly used anticoagulant with a narrow therapeutic range and risk of hemorrhagic complications. After CYP2C9 and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)